Irradiation and Blood Vessel Prostaglandin Metabolism

Part of the Prostaglandins, Leukotrienes, and Cancer book series (PLAC, volume 5)


Nowadays, it is well known, that tissue damage is associated with thrombosis of vessels in irradiated areas. As early as in 1944 Sheehan (43) was the first relating the foam cell plaque formation to an effect of irradiation. Warren (61) reported in 1942 atherosclerosis-like lesions. Later on, a number of experimental studies have been performed in order to elucidate the pathomechanism of irradiation- induced vasculopathy showing in rat (2), chicken (58) and swine (30) that irradiation accelerates the development of atherosclerosis. Endothelial damage (9, 10, 25, 27, 28, 29, 57), increased vascularwallpermeability(35), enhanced mitotic activity (14, 44, 46) and parietal thrombus formation (6, 15, 16) have been shown to be early mechanisms involved. Human data provide evidence for cerebrovascular consequences (7) and the development of coronary heart disease induced by irradiation (5, 38). Although all these mechanisms together with the finding, that aspirin reduces the severity of radiation-induced vascular lesions (56) indicate, that the prostaglandin (PG)-system is involved to an important extent too, there is only limited information available so far concerning the importance of the PG-systemin the blood-vessel wall interaction during and after irradiation.


Cervical Cancer Arachidonic Acid Aggregation Response Control Segment Serum TXB2 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Men, S.B., Sagerman, R.H. and Stuart, M.J. Lancet ii: 1193–1196, 1981.Google Scholar
  2. 2.
    Amromin, G.D., Gildenhorn, H.L., Solman, R.D., Nodkarni, B.B. and Jacobi, M.L. J. Atheroscler. Res. 4: 325–334, 1964.PubMedCrossRefGoogle Scholar
  3. 3.
    Baluda, V.P., Sushkevich, G.N., Parshkov, E.M. and Lukoianova, T.I. Bull. Eksp. Biol. Med. 91: 559–562, 1981.CrossRefGoogle Scholar
  4. 4.
    Baluda, V.P., Sushekwich, G.N., Parshkow, E.M. and Lukoyanova, T.I. Zakbla Medizinski. 62: 243–247, 1982.Google Scholar
  5. 5.
    Brosius, F.C., Woller, B.F. and Roberts, W.C. Amer. J. Med. 70: 519–530, 1981.PubMedCrossRefGoogle Scholar
  6. 6.
    Brown, J.M., Fajardo, L.F. and Stewart, R J. Arch.Pathol. 96: 1–8, 1973.Google Scholar
  7. 7.
    Conomy, J.P. and Kellermeyer, R.W. Cancer 36: 1702–1708, 1975.PubMedCrossRefGoogle Scholar
  8. 8.
    Coughlin, S., Moshkowitz, M. A., Zellev, P.R., Antoniades, H.N. and Levine, G. Nature 188: 5791–5794, 1980.Google Scholar
  9. 9.
    DeBoer, W.G.R.M. thesis, Univ. Groningen, 1963.Google Scholar
  10. 10.
    DeGowin, R.L., Lewis, J.L., Hoak, J.C., Mueller, A.L. and Gibson, D.P. J. Lab. Clin. Med. 84: 42–48, 1974.Google Scholar
  11. 11.
    Eldor, A., Vlodavsky, I., Hy Am, E., Atzmon, R. and Fuks, Z. Prostaglandins 25: 263–279, 1983.PubMedCrossRefGoogle Scholar
  12. 12.
    Eldor, A.: Pers. communication, 1986.Google Scholar
  13. 13.
    Eldor, A., Cohen, M., Vlodavsky, I., Pazin, E., Hy Am, E., Fuks, Z. and Matzner, Y. Int. Conf. Prostaglandins and Lipid Metabolism inRadiation Injury, Washington 1986, “Abstract book”, pp. 83.Google Scholar
  14. 14.
    Fajardo, L.F. and Stewart, L.R. Amer. J. Pathol. 59: 299–306, 1970.Google Scholar
  15. 15.
    Fajardo, L.F. and Brown, M.J. Rad. Res., 55: 387–389, 1973.CrossRefGoogle Scholar
  16. 16.
    Fajardo, L.F. and Stewart, L.R. Lab. Invest. 29: 244–257, 1973.PubMedGoogle Scholar
  17. 17.
    Fogelman, A.M., Shehter, I., Slager, J., Hokam, M., Child, J.S., Edwards, P.A. Proc. Nat. Acad. Sci. USA 77: 2214–2218, 1980.PubMedCrossRefGoogle Scholar
  18. 18.
    Friedman, M., Saunders, D.S., Madden, M.C., Chaney, E.L. and Kwock, L. Radiat. Res. 106: 171–181, 1986.PubMedCrossRefGoogle Scholar
  19. 19.
    Gabrielian, E.S., Akopov, S.E., Kharatian, A.A. and Petrosian, A.K. Biull. Eksp. Biol. Med. 101:79–81, 1986.PubMedGoogle Scholar
  20. 20.
    Gerrard, J.M. In: Prostaglandins and Leukotrienes. Blood and Vascular Cell Function. Marcel Dekker Inc., New York, Basel, 1985, pp. 222.Google Scholar
  21. 21.
    Gitsch E. In: Gynakologie, (Eds. Gitsch E, Janisch H.) Wilhelm Maudrich, Wien-München-Bern, 1984, p. 103.Google Scholar
  22. 22.
    Hahn, G.L., Menconi, M.J., Cahill, M. and Polgar, P. Prostaglandins 25: 783–791, 1983.PubMedCrossRefGoogle Scholar
  23. 23.
    Hajjar, D.P. Biochem. Pharmacol. 34: 295–300, 1985.PubMedCrossRefGoogle Scholar
  24. 24.
    Heinz, T.R., Schneidkraut, M.Y., Kot, P.A., Ramwell, P.W. and Rose, J.C. Biochem. Pharmacol. 20: 74–83, 1985.Google Scholar
  25. 25.
    Hirst, D.G., Denekamp, J. and Travis, E.L. Radiat. Res. 77: 259–275, 1979.PubMedCrossRefGoogle Scholar
  26. 26.
    Kieback, D.G., Briel, R.R., Schneider, A.I., Schmucker, R.G.A. and Lippert, T.H. Thromb. Haemost. 50: 455, 1983.Google Scholar
  27. 27.
    Lamberts, H.B. In: Symposium on the cellular basis and etiology of late somatic effects of ionizing radiation, (Eds. H. Lamberts), Academic press, New York, 1963, pp. 106–125.Google Scholar
  28. 28.
    Law, M.P. and Thomlinson, R.H. Brit. J. Radiol. 51: 845–904, 1978.Google Scholar
  29. 29.
    Law, M.P. Adv. Radiation Biol. 9: 37–93, 1981.Google Scholar
  30. 30.
    Lee, K.T., Jarmolych, S., Kim, D.N., Grant, C., Krasney, J.A., Thomas, W. A. and Bruno, A.M. Exp. Molec. Pathol. 15:170–190, 1971.CrossRefGoogle Scholar
  31. 31.
    Lindsay, S, Kohn, H.I., Dakin, R. and Jew, J. Circ. Res. 10: 51–56, 1962.PubMedGoogle Scholar
  32. 32.
    Marcial-Rojas, R.A. and Castro, J.R. Ann. ORL. 21:745–750, 1962.Google Scholar
  33. 33.
    Menconi, M.J., Taylor, L. and Polgar, P. Int. Conf. Prostaglandins and Lipid Metabolism in Radiation Injury, Washington 1986, “Abstract book”, pp. 19.Google Scholar
  34. 34.
    Moncada, S., Gryglewski, R., Bunting, S. and Vane, J.R. Nature 263: 663–665, 1976.PubMedCrossRefGoogle Scholar
  35. 35.
    Neumayr, A. and Thurnher, B. Strahlentherapie 84: 297–302, 1951.PubMedGoogle Scholar
  36. 36.
    Reichel, R., Husslein, P., Kucera, H. and Sinzinger, H. In: Prostaglandins in Clinic and Research, (Eds. Sinzinger, H. and Schrör, K.), Alan R. Liss, New York, 1987, in press.Google Scholar
  37. 37.
    Reinhold, H.S. and Buisman, G.H. Brit. J. Radiol. 46: 54–57, 1973.PubMedCrossRefGoogle Scholar
  38. 38.
    Mc Reynolds, R.A., Gold, G.L. and Roberts, W.C. Amer. J. Med. 60: 39–45, 1976.CrossRefGoogle Scholar
  39. 39.
    Ross, R., Glomset, J., Kariya, B. and Harker, L. Proc. US Nat. Acad. Sci. 74: 1207–1210, 1974.CrossRefGoogle Scholar
  40. 40.
    Rubin, D.B., Drab, E.A., Tsao, C.H., Gardner, D. and Ward, W.F. J. Appl. Physiol. 58: 592–597, 1985.PubMedGoogle Scholar
  41. 41.
    Schneidkraut, M.J., Kot, P.A. and Ramwell, P.W. Adv. PG TX LT Res. 12: 107, 1983.Google Scholar
  42. 42.
    Schneidkraut, M.J., Kot, P.A. and Ramwell, P.W. and Rose, J.C. J. Appl. Physiol. 57: 833–838 1984PubMedGoogle Scholar
  43. 43.
    Sheehan, J.F. Arch. Pathol. 37: 297–303, 1944.Google Scholar
  44. 44.
    Silberbauer, K., Willvonseder, R., Feigl, W., Krisch, K. and Sinzinger, H. VASA 5: 215–223, 1976.PubMedGoogle Scholar
  45. 45.
    Silberbauer, K., Willvonseder, R., Feigl, W. Leithner, Ch. and Sinzinger, H. VASA 6: 183–187, 1977.PubMedGoogle Scholar
  46. 46.
    Sinzinger, H., Wicke, L., Willvonseder, R., Hernuss, P., Müller-Tyl, E. and Erd, W. Acta Morphol. Neerl. Scand. 14: 201–208, 1976.PubMedGoogle Scholar
  47. 47.
    Sinzinger, H., Silberbauer, K. and Auerswald, W. Blood Vessels 17: 58–60, 1980.PubMedGoogle Scholar
  48. 48.
    Sinzinger, H., Schemthaner, G. and Kaliman, J. Prostaglandins 22: 773–781, 1981.PubMedCrossRefGoogle Scholar
  49. 49.
    Sinzinger, H., Firbas, W. and Cromwell, M. Prostaglandins 24: 323–329, 1982.PubMedCrossRefGoogle Scholar
  50. 50.
    Sinzinger, H., Kefalides, A. and Hoche, Ch. Circulation 66: 192, 1982.Google Scholar
  51. 51.
    Sinzinger, H., Fitbas, W. and Cromwell, M. Wr. Klin. Wschr. 21: 761–765, 1983.Google Scholar
  52. 52.
    Sinzinger, H., Fitbas, W. and Cromwell, M. Rad. Res. 97: 533–536, 1984.CrossRefGoogle Scholar
  53. 53.
    Sinzinger, H. and Firbas, W. Brit. J. Radiol. 58: 1023–1026, 1985.PubMedCrossRefGoogle Scholar
  54. 54.
    Sinzinger, H., Reiter, Sonja and Peskar, B.A. In: Prostaglandins and other Eicosanoids in the Cardiovascular System, (Eds. Schrör K.), Karger Verlag, Basel, 1985, pp. 62–67.Google Scholar
  55. 55.
    Sinzinger, H., Cromwell, M. and Firbas, W. Strahlentherapie und Onkologie 162: 592–595, 1986PubMedGoogle Scholar
  56. 56.
    Smit Sibinga, C.T. Bibl. Anat. 12: 242–248, 1973.PubMedGoogle Scholar
  57. 57.
    Smith, C. and Loewenthal, A. Proc. Soc. Exp. Biol. Med. 75: 859, 1950.PubMedGoogle Scholar
  58. 58.
    Stearner, S.P. and Sanderson, M.H. Rad. Res. 49: 328–336, 1972.CrossRefGoogle Scholar
  59. 59.
    Tsao, C.H., Ward, W.F. and Port, C.D. 96: 284–293, 1983.Google Scholar
  60. 60.
    Weksler, Z., Raz, A., Rosenman, E., Biran, S., Fuks, Z. and Eldor, A. Int. Conf. Prostaglandins and Lipid Metabolism in Radiation Injury, Washington, 1986, Abstract book”, pp. 85.Google Scholar
  61. 61.
    Warren, S. Arch. Path. 34: 1070–1076, 1942.Google Scholar
  62. 62.
    Willis, A.L., Smith, D.L., Vigo, C. and Kluge, A.F. Lancet ii: 682–683, 1986.CrossRefGoogle Scholar
  63. 63.
    Zollinger, H. Pathol. Europ. 5: 45–57, 1970.Google Scholar

Copyright information

© Kluwer Academic Publishers, Boston 1988

Authors and Affiliations

  1. 1.Dept. of Nuclear Medicine, Atherosclerosis Research Group (ASF), 1st Dept. of Gynecology and Obstetrics(R.R.)University of ViennaVienna(H.S.)Austria

Personalised recommendations